These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 30075404)
1. Novel coumarin-pyrazole carboxamide derivatives as potential topoisomerase II inhibitors: Design, synthesis and antibacterial activity. Liu H; Ren ZL; Wang W; Gong JX; Chu MJ; Ma QW; Wang JC; Lv XH Eur J Med Chem; 2018 Sep; 157():81-87. PubMed ID: 30075404 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel multi-substituted benzo-indole pyrazole schiff base derivatives with antibacterial activity targeting DNA gyrase. Liu H; Chu ZW; Xia DG; Cao HQ; Lv XH Bioorg Chem; 2020 Jun; 99():103807. PubMed ID: 32272364 [TBL] [Abstract][Full Text] [Related]
3. Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase Inhibitors: Design, synthesis, and antibacterial activity. Liu H; Xia DG; Chu ZW; Hu R; Cheng X; Lv XH Bioorg Chem; 2020 Jul; 100():103907. PubMed ID: 32413631 [TBL] [Abstract][Full Text] [Related]
4. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity. Kassab AE; Gedawy EM Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830 [TBL] [Abstract][Full Text] [Related]
5. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV. Metwally NH; Abdallah SO; Mohsen MMA Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481 [TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel Triazole-Containing Pyrazole Ester Derivatives as Potential Antibacterial Agents. Chu MJ; Wang W; Ren ZL; Liu H; Cheng X; Mo K; Wang L; Tang F; Lv XH Molecules; 2019 Apr; 24(7):. PubMed ID: 30987179 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, and antibacterial activity of novel 4,5-dihydro-1H-pyrazole derivatives as DNA gyrase inhibitors. Liu JJ; Sun J; Fang YB; Yang YA; Jiao RH; Zhu HL Org Biomol Chem; 2014 Feb; 12(6):998-1008. PubMed ID: 24382549 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel flavone Mannich base derivatives as potential antibacterial agents. Lv XH; Liu H; Ren ZL; Wang W; Tang F; Cao HQ Mol Divers; 2019 May; 23(2):299-306. PubMed ID: 30168050 [TBL] [Abstract][Full Text] [Related]
9. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity. Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469 [TBL] [Abstract][Full Text] [Related]
10. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study. Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV. Hofny HA; Mohamed MFA; Gomaa HAM; Abdel-Aziz SA; Youssif BGM; El-Koussi NA; Aboraia AS Bioorg Chem; 2021 Jul; 112():104920. PubMed ID: 33910078 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of naphthoquinone-coumarin conjugates as topoisomerase II inhibitors. Hueso-Falcón I; Amesty Á; Anaissi-Afonso L; Lorenzo-Castrillejo I; Machín F; Estévez-Braun A Bioorg Med Chem Lett; 2017 Feb; 27(3):484-489. PubMed ID: 28040393 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors. Yao BL; Mai YW; Chen SB; Xie HT; Yao PF; Ou TM; Tan JH; Wang HG; Li D; Huang SL; Gu LQ; Huang ZS Eur J Med Chem; 2015 Mar; 92():540-53. PubMed ID: 25599951 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl)urea derivatives as Escherichia coli DNA gyrase inhibitors. Tomašič T; Barančoková M; Zidar N; Ilaš J; Tammela P; Kikelj D Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29239018 [TBL] [Abstract][Full Text] [Related]
15. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity. Omar MA; Masaret GS; Abbas EMH; Abdel-Aziz MM; Harras MF; Farghaly TA Bioorg Chem; 2020 Nov; 104():104316. PubMed ID: 33022549 [TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of Staphylococcus aureus DNA gyrase and topoisomerase IV activity by phenylalanine-derived (Z)-5-arylmethylidene rhodanines. Werner MM; Patel BA; Talele TT; Ashby CR; Li Z; Zauhar RJ Bioorg Med Chem; 2015 Sep; 23(18):6125-37. PubMed ID: 26320664 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors. Ibrahim MK; Taghour MS; Metwaly AM; Belal A; Mehany ABM; Elhendawy MA; Radwan MM; Yassin AM; El-Deeb NM; Hafez EE; ElSohly MA; Eissa IH Eur J Med Chem; 2018 Jul; 155():117-134. PubMed ID: 29885574 [TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Evaluation of Novel Tyrosine-Based DNA Gyrase B Inhibitors. Cotman AE; Trampuž M; Brvar M; Kikelj D; Ilaš J; Peterlin-Mašič L; Montalvão S; Tammela P; Frlan R Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28621824 [TBL] [Abstract][Full Text] [Related]
20. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents. Alagumuthu M; Arumugam S Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]